Calunsag, Bb Girl .
HRN: 25-84-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/18/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/18/2024
09/25/2024
IV
45mg
Q24h
PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes